(Q34346290)

1 August 2017

1 reference

title

Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management (English)

1 reference

1 August 2017

M Behrend

1

1 reference

1 August 2017

1 January 2001

1 reference

1 August 2017

1 reference

1 August 2017

24

1 reference

1 August 2017

9

1 reference

1 August 2017

645-663

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-200124090-00002

1 August 2017

0 references

cites work

Mycophenolate mofetil in IBD patients

1 reference

12 December 2020

Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease

1 reference

12 December 2020

The inhibition of nucleic acid synthesis by mycophenolic acid

1 reference

12 December 2020

Prevalence of cytomegalovirus in the gastrointestinal tract of renal transplant recipients with persistent abdominal pain

1 reference

12 December 2020

The design and development of an immunosuppressive drug, mycophenolate mofetil

1 reference

12 December 2020

Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).

1 reference

12 December 2020

Ganciclovir. An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients.

1 reference

12 December 2020

Tolerability profile of sodium mycophenolate (ERL080) and mycophenolate mofetil with and without cyclosporine (Neoral) in the rat.

1 reference

12 December 2020

Glutamine and nucleotide metabolism within enterocytes

1 reference

12 December 2020

Pharmacokinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Reci

1 reference

12 December 2020

Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid

1 reference

12 December 2020

A prospective randomized trial of mycophenolate mofetil with neoral or tacrolimus after orthotopic liver transplantation

1 reference

12 December 2020

A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATION

1 reference

12 December 2020

Therapy of rheumatoid arthritis with mycophenolate mofetil.

1 reference

12 December 2020

Mycophenolate mofetil (Cellcept)

1 reference

12 December 2020

Mycophenolate mofetil versus azathioprine in patients with chronic active ulcerative colitis: a 12-month pilot study

1 reference

12 December 2020

RS-61443 (mycophenolate mofetil). A multicenter study for refractory kidney transplant rejection

1 reference

12 December 2020

Mycophenolate mofetil monotherapy in stable liver transplant patients with cyclosporine-induced renal impairment: a preliminary report

1 reference

12 December 2020

Induction of inosine monophosphate dehydrogenase activity after long-term treatment with mycophenolate mofetil

1 reference

12 December 2020

Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus

1 reference

12 December 2020

Mycophenolate mofetil: suggested guidelines for use in kidney transplantation

1 reference

12 December 2020

Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression.

1 reference

12 December 2020

Mycophenolate mofetil-induced hyperbilirubinemia in renal transplant recipients

1 reference

12 December 2020

Is cytomegalovirus infection related to mycophenolate mofetil after kidney transplantation? A case-control study.

1 reference

12 December 2020

Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients

1 reference

12 December 2020

Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group

1 reference

12 December 2020

RS-61443--a new, potent immunosuppressive agent

1 reference

12 December 2020

Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil.

1 reference

12 December 2020

Steroid-free immunosuppression after renal transplantation

1 reference

12 December 2020

Mycophenolate Mofetil for Treatment of Active Inflammatory Bowel Disease: Clinical and Immunological Studies

1 reference

12 December 2020

A prospective, randomized trial of tacrolimus/prednisone versus tacrolimus/prednisone/mycophenolate mofetil in renal transplant recipients

1 reference

12 December 2020

Mycophenolate mofetil--is it worth the cost? The in-favor opinion

1 reference

12 December 2020

Co-administration of tacrolimus and mycophenolate mofetil does not increase mycophenolic acid (MPA) exposure, but co-administration of cyclosporine inhibits the enterohepatic recirculation of MPA, thereby decreasing its exposure

1 reference

12 December 2020

1 reference

12 December 2020

Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts

1 reference

12 December 2020

Preferential suppression of lymphocyte proliferation by mycophenolic acid and predicted long-term effects of mycophenolate mofetil in transplantation

1 reference

12 December 2020

Pharmacokinetics of mycophenolate mofetil (RS61443): a short review.

1 reference

12 December 2020

A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group

1 reference

12 December 2020

Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group

1 reference

12 December 2020

Mycophenolate mofetil for rescue therapy in acute renal transplant rejection in children should always be monitored by measurement of trough concentration

1 reference

12 December 2020

Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings

1 reference

12 December 2020

Tacrolimus and mycophenolate mofetil in renal transplant recipients: one year results of a multicenter, randomized dose ranging trial. FK506/MMF Dose-Ranging Kidney Transplant Study Group

1 reference

12 December 2020

Inosine-5'-monophosphate dehydrogenase: regulation of expression and role in cellular proliferation and T lymphocyte activation.

1 reference

12 December 2020

The influence of mycophenolate mofetil on the incidence and severity of primary cytomegalovirus infections and disease after renal transplantation

1 reference

12 December 2020

Mycophenolate mofetil in pediatric renal transplantation

1 reference

12 December 2020

Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil

1 reference

12 December 2020

Mycophenolate mofetil-induced ischemic colitis

1 reference

12 December 2020

A prospective, randomized trial to compare tacrolimus and prednisone with and without mycophenolate mofetil in patients undergoing renal transplantation: first report

1 reference

12 December 2020

Evidence that tacrolimus augments the bioavailability of mycophenolate mofetil through the inhibition of mycophenolic acid glucuronidation

1 reference

12 December 2020

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation

1 reference

12 December 2020

What is the role for mycophenolate mofetil in pediatric renal transplantation?

1 reference

12 December 2020

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

1 reference

12 December 2020

Experience with mycophenolate mofetil (RS61443) in renal transplantation at a single center

1 reference

12 December 2020

Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients

1 reference

12 December 2020

Randomized study on the conversion of treatment with cyclosporine to azathioprine or mycophenolate mofetil followed by dose reduction

1 reference

12 December 2020

Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups

1 reference

12 December 2020

A prospective, randomized trial of FK 506/prednisone vs FK 506/azathioprine/prednisone in renal transplant patients.

1 reference

12 December 2020

1 reference

12 December 2020

Mycophenolate mofetil improves long-term graft survival following renal transplantation in patients experiencing delayed graft function. International Mycophenolate Mofetil Renal Study Groups

1 reference

12 December 2020

FK 506 in the treatment of steroid- and OKT3-resistant rejection in renal transplant recipients: reduced dosage and anti-infective prophylaxis

1 reference

12 December 2020

Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites

1 reference

12 December 2020

Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation.

1 reference

12 December 2020

Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipients

1 reference

12 December 2020

Safety of the mycophenolate mofetil-allopurinol combination in kidney transplant recipients with gout

1 reference

12 December 2020

Cytomegalovirus infection and abdominal pain with mycophenolate mofetil: is there a link?

1 reference

12 December 2020

Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. U.S. Renal Transplant Mycophenolate Mofetil Study Group

1 reference

12 December 2020

A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation.

1 reference

12 December 2020

Intestinal adaptation to diabetes. Altered Na-dependent nutrient absorption in streptozocin-treated chronically diabetic rats

1 reference

12 December 2020

Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients

1 reference

12 December 2020

Pharmacokinetics of mycophenolic acid (MPA) and free MPA in paediatric renal transplant recipients--a multicentre study. The German Study Group on Mycophenolate Mofetil (MMF) Therapy

1 reference

12 December 2020

Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group

1 reference

12 December 2020

Comparison of two corticosteroid regimens in combination with CellCept and cyclosporine A for prevention of acute allograft rejection: 12 month results of a double-blind, randomized, multi-center study. M 55002 Study Group

1 reference

12 December 2020

Mycophenolate mofetil may induce apoptosis in duodenal villi

1 reference

12 December 2020

A review of clinical experience with the novel immunosuppressive drug mycophenolate mofetil in renal transplantation

1 reference

12 December 2020

Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients

1 reference

12 December 2020

Mycophenolate mofetil in cardiac transplantation.

1 reference

12 December 2020

Effect of adding Mycophenolate mofetil in paediatric renal transplant recipients with chronical cyclosporine nephrotoxicity.

1 reference

12 December 2020

Mycophenolic acid plasma concentrations: influence of comedication

1 reference

12 December 2020

Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients

1 reference

12 December 2020

Coadministration of tacrolimus and mycophenolate mofetil in stable kidney transplant patients: pharmacokinetics and tolerability

1 reference

12 December 2020

The effect of renal insufficiency on mycophenolic acid protein binding

1 reference

12 December 2020

RS-61443--a phase I clinical trial and pilot rescue study

1 reference

12 December 2020

Nutritional and intestinal effects of the novel immunosuppressive agents: Deoxyspergualin, rapamycin, and mycophenolate mofetil

1 reference

12 December 2020

Immunological observations on patients with Lesch-Nyhan syndrome, and on the role of de-novo purine synthesis in lymphocyte transformation

1 reference

12 December 2020

Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil

1 reference

12 December 2020

Adverse effects of mycophenolate mofetil in pediatric renal transplant recipients with presumed chronic rejection

1 reference

12 December 2020

Trough blood concentrations in long-term treatment with mycophenolate mofetil

1 reference

12 December 2020

Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study

1 reference

12 December 2020

Is mycophenolate mofetil a new alternative in the treatment of inflammatory bowel disease?

1 reference

12 December 2020

Human type I and II IMP dehydrogenases as drug targets

1 reference

12 December 2020

Comparison of three immunosuppressive regimens in cadaver renal transplantation: long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine

1 reference

12 December 2020

Nucleoside-phosphorylase deficiency in a child with severely defective T-cell immunity and normal B-cell immunity

1 reference

12 December 2020

Conversion from azathioprine [correction of azathioprina] to mycophenolate mofetil in pediatric renal transplant recipients with chronic rejection

1 reference

12 December 2020

Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy

1 reference

12 December 2020

Mycophenolate mofetil for prevention of liver allograft rejection: initial results of a controlled clinical trial

1 reference

12 December 2020

Mycophenolate mofetil. A review of its pharmacodynamic and pharmacokinetic properties and clinical efficacy in renal transplantation

1 reference

12 December 2020

Pediatric renal transplantation without steroids

1 reference

12 December 2020

The effect of immunosuppressive drugs on quality of life after renal transplantation.

1 reference

12 December 2020

The use of mycophenolate mofetil (RS-61443) in human heart transplant recipients

1 reference

12 December 2020

INTESTINAL MICROSPORIDIOSIS OCCURRING IN TWO RENAL TRANSPLANT RECIPIENTS TREATED WITH MYCOPHENOLATE MOFETIL

1 reference

12 December 2020

Mycophenolate mofetil in cadaveric renal transplantation. US Renal Transplant Mycophenolate Mofetil Study Group

1 reference

12 December 2020

Trends in immunosuppressive therapy: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS)

1 reference

12 December 2020

Mycophenolic acid plasma concentrations in kidney allograft recipients with or without cyclosporin: a cross-sectional study

1 reference

12 December 2020

Mycophenolate mofetil

1 reference

12 December 2020

Limited sampling strategy for mycophenolic acid area under the curve

1 reference

12 December 2020

Mycophenolate mofetil-induced villous atrophy

1 reference

12 December 2020

Development of cytomegalovirus resistance to ganciclovir after oral maintenance treatment in a renal transplant recipient.

1 reference

12 December 2020

Treatment of steroid refractory inflammatory bowel disease (IBD) with mycophenolate mofetil (MMF)

1 reference

12 December 2020

A comparative analysis of the use of mycophenolate mofetil in pediatric vs. adult renal allograft recipients

1 reference

12 December 2020

Identification of a pharmacologically active metabolite of mycophenolic acid in plasma of transplant recipients treated with mycophenolate mofetil

1 reference

12 December 2020

10.2165/00002018-200124090-00002

Identifiers

DOI

1 reference

PubMed ID

11522119

Dimensions Publication ID

1 August 2017

0 references

1 reference

PubMed ID

11522119